Andrew Martin provides consultancy and expert witness services covering:
After obtaining a 1st Class Honours in Biochemistry at the University of Oxford he stayed in Oxford for a D.Phil., during which he developed the first automated method for modelling antibody structure, later commercialized by Oxford Molecular.
After working at the National Institute for Medical Research in London and a few years as a self-employed scientific software developer, he joined the group of Professor Dame Janet Thornton, FRS at University College London. He moved from there to Inpharmatica, a UCL spin-out company, and then to the University of Reading as a Lecturer in Bioinformatics. He returned to UCL in 2004 where he is now an Emeritus Professor of Bioinformatics and Computational Biology. In addition to abYinformatics, Ltd., he is co-founder of abYsis, Ltd., a UCL spinout company that continues the development and marketing of the abYsis software originally developed in his research group.
His research focuses on two main areas:
He has an H-index of 50 having published over 80 papers and reviews, six book chapters and a co-authored book on moonlighting proteins. As well as widely used web-based software for working with antibodies and with other proteins, he has developed software that has been downloaded over 8,000 times.
He has consulted and done contracting for a number of companies (mostly related to antibody humanization and developability) including:
He has also acted as an expert witness in several patent disputes related both to antibodies and to general bioinformatics. He has been involved in more than 17 cases in the UK, US, EU, and Ireland. Key cases include:
He is also an advisor to the WHO International Nonproprietary Names (INN) committee on the naming and annotation of antibody-based drugs.
| • bioinf.org.uk | Research pages |
| • abysis.org | abYsis software |
| • abybank.org | Antibody sequence and structure data resources |
| • AndrewCRMartin (@Github) | Software from Andrew Martin |
| • ACRMGroup (@Github) | Software from the Martin group |
EMail: